Cargando…

What about incorporating selenium in the therapeutic regimen of SARS-CoV-2?

Detalles Bibliográficos
Autores principales:	Benarba, Bachir, Pandiella, Atanasio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Leibniz Research Centre for Working Environment and Human Factors 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744964/ https://www.ncbi.nlm.nih.gov/pubmed/33343271 http://dx.doi.org/10.17179/excli2020-2968

Ejemplares similares

Medicinal Plants as Sources of Active Molecules Against COVID-19
por: Benarba, Bachir, et al.
Publicado: (2020)

Use of medicinal plants by breast cancer patients in Algeria
por: Benarba, Bachir
Publicado: (2015)

Red and processed meat and risk of colorectal cancer: an update
por: Benarba, Bachir
Publicado: (2018)

Secret hiding places in the eye and beyond: what about after SARS-CoV-2 infection?
por: Erren, Thomas C., et al.
Publicado: (2021)

SARS-CoV-2 in animals: what about the cat?
por: Teixeira, Ana Izabel Passarella
Publicado: (2021)

SARS-CoV-2 and the myths about vaccination()
por: Travezaño-Cabrera, Aaron, et al.
Publicado: (2021)

No secret hiding place on the ocular surface: what about after systemic SARS-CoV-2 infection?
por: Rokohl, Alexander C., et al.
Publicado: (2021)

What Is New With Omicron Variant of SARS-CoV-2 in Children?
por: Bittmann, Stefan, et al.
Publicado: (2022)

Hearing Loss in SARS-CoV-2: What Do We Know?
por: Saniasiaya, Jeyasakthy
Publicado: (2021)

What the neuroradiologist should additionally consider in SARS-CoV-2 infection
por: Finsterer, J., et al.
Publicado: (2020)

Facing the SARS-CoV-2 Outbreak: What Should Obstetricians and Gynecologists Do?
por: Zhang, Hongyuan, et al.
Publicado: (2020)

Asymptomatic SARS-CoV-2 infections: What do we need to know?
por: Tan, Caixia, et al.
Publicado: (2020)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill?
por: Salhotra, Ripenmeet
Publicado: (2023)

What is the long‐term clinical significance of anti‐SARS‐CoV‐2‐specific IgG?
por: Alberca, Gabriela Gama Freire, et al.
Publicado: (2020)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Impact of therapeutic plasma exchange on acquired vaccinal anti-SARS-CoV-2 antibodies
por: Lambert, Catherine, et al.
Publicado: (2022)

Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection
por: Mandato, Claudia, et al.
Publicado: (2021)

What Is Needed to Make Interventional Radiology Ready for COVID-19? Lessons from SARS-CoV Epidemic
por: Pua, Uei, et al.
Publicado: (2020)

Update on SARS-CoV-2 vaccination of patients with inflammatory bowel disease: what clinicians need to know
por: Lee, Yoo Jin, et al.
Publicado: (2022)

A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV
por: Xie, Dongying, et al.
Publicado: (2021)

SARS CoV-2 genetic jump to a new SARS CoV-3 pandemic: Let’s be prepared
por: Kelleni, Mina T.
Publicado: (2023)

Humoral and cellular responses after third dose of SARS-CoV-2 vaccine in myeloproliferative neoplasms patients on ruxolitinib therapy
por: Atanasio, A., et al.
Publicado: (2023)

Kappa Values in Testing the Concordance: Comments on a Recent Article about Nasopharyngeal Swabs for SARS-CoV-2 Detection
por: Li, Ming, et al.
Publicado: (2022)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

SARS‐CoV‐2 immunogenicity at the crossroads
por: Karamloo, Fariba, et al.
Publicado: (2020)

Transmission routes of SARS-CoV-2
por: Patel, Jay
Publicado: (2020)

SARS-CoV-2 and EBV coinfection()
por: García-Martínez, Francisco Javier, et al.
Publicado: (2020)

Peptide Targets to SARS-CoV-2
por: Mandal, Santi M.
Publicado: (2020)

On aerosol transmission of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2021)

Living evidence for SARS-CoV-2()
por: Santillan-Garcia, A.
Publicado: (2021)

Is SARS-CoV-2 an oncogenic virus?
por: Gómez-Carballa, Alberto, et al.
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Routes of transmission of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

SARS-CoV-2 and Legionella Co-Infection
por: Gauvin, Caitlin A., et al.
Publicado: (2023)

Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
por: Pavoni, Vittorio, et al.
Publicado: (2020)

SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP()
por: Zúñiga, José, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rdecu0pvjqua9sdi6p19dk7f63